Semaglutides
The GLP-1 market

The Cheapest Place to Buy Wegovy or Zepbound Right Now

As of 2026 price snapshots, the lowest posted self-pay prices run from $149 a month for oral GLP-1s at Amazon Pharmacy to $299-$449 for Zepbound through LillyDirect, with CVS voucher pricing as low as $149. Verify every price before buying, since several are introductory or time-limited.

Last checked ·8 sources cited·WegovyZepbound
Isometric clay scene of an injection pen, price tag and coins on a checkout counter with a shopping bag.

Semaglutides.org provides information only, not medical advice. Talk to a licensed provider about your own care before making changes. Some telehealth links are affiliate links and are labeled where they appear.

The cheapest legitimate way to buy Wegovy or Zepbound in the US right now is through a direct-to-consumer channel — the manufacturer’s own site, a big retailer’s pharmacy, or a telehealth program — not by walking into a traditional pharmacy counter. Posted self-pay prices in 2026 snapshots run from $149 per month for oral GLP-1 pills at Amazon Pharmacy [6] up to $299 to $449 a month for Zepbound vials through LillyDirect [3][7]. At CVS Pharmacy, uninsured patients using a manufacturer voucher on qualifying medications and doses can pay as little as $149, and insured patients with a manufacturer coupon can pay as little as $25 a month [8]. For comparison, walking into a brick-and-mortar pharmacy and paying cash without one of these programs is often quoted upwards of $1,000 [4].

Every figure below is a self-pay, cash, or coupon price from a 2026 snapshot, not a list price, and several are introductory or time-limited. Confirm the current price at checkout before you buy, because these numbers have been changing quickly [3][5][6].

What do the posted cash prices look like side by side?

ChannelProductPosted self-pay priceConditionsSnapshot
LillyDirectZepbound single-dose vials$299 to $449 a monthBetter pricing tied to refilling within 45 daysEffective December 1, 2025 [3][7]
NovoCareWegovy or Ozempic injectables$199 for the first two months, then $349New self-pay patients, 0.25 mg or 0.5 mg doses2026 snapshot [3][7]
Amazon PharmacyWegovy pill, Foundayo (oral)From $149 per monthCash-pay option2026 snapshot [6]
Amazon PharmacyWegovy injectable, Zepbound auto-injector and KwikPenFrom $299 per monthCash-pay option2026 snapshot [6]
Costco (Sesame partnership)WegovyAround $349 a monthCostco membership required ($65 card)2026 snapshot [3]
CVS PharmacyGLP-1 medicationsAs low as $149 uninsured; as low as $25 with commercial insuranceManufacturer voucher for qualifying meds and doses; coupon for eligible insured patients2026 snapshot [8]
TrumpRx-listedVarious GLP-1 brands and forms$149 to $299 per monthSome reduced prices are time-limited2026 snapshot [5]

The TrumpRx website lists costs of $149 to $299 per month across GLP-1 brands and forms, and some of those reduced costs only last for a limited time [5].

Is paying cash actually how most people get these drugs now?

Yes, for a growing share of buyers, and the shift happened fast. The Wegovy pill launched in the US in January 2026 as the first oral GLP-1 approved for obesity [2]. Within eight weeks, it had captured around one-third of new-to-brand prescriptions, with the majority of that volume flowing through cash-pay channels [2]. Around two-thirds of oral Wegovy users were new to any GLP-1 therapy, which suggests lower prices and convenience are pulling in new patients rather than just moving injectable users to a pill [2].

The overall numbers are large. Novo Nordisk reported total weekly Wegovy prescriptions in the US of around 575,000 for the week ending July 17, 2026, including more than 265,000 weekly prescriptions for the Wegovy pill and more than 5 million pill prescriptions since launch [1].

Employer coverage is moving in the opposite direction. A Mercer survey showed 6% of large employers dropped GLP-1 coverage this year, while the drugs’ share of claims swelled to 11.4%, up from 6.9% in 2023 [3]. Cigna said it would stop covering the medicines for its own employees [3]. As employers step back, more patients are being pointed toward direct-to-consumer platforms [3].

What do LillyDirect and NovoCare charge, and what are the catches?

LillyDirect’s Zepbound self-pay pricing, effective December 1, 2025, puts the 2.5 mg single-dose vial at $299 a month (a $50 cut), the 5 mg vial at $399 a month (a $100 cut), and the 7.5 mg, 10 mg, 12.5 mg, and 15 mg vials at $449 a month, down from $499 [7]. LillyDirect connects patients with independent telehealth providers, and fulfillment runs through third-party online pharmacy services with home delivery [7].

The catch on LillyDirect is timing: the better pricing is tied to refilling within 45 days [3]. Jackie Swanson, managing partner at Gartner Consulting, called that “a loyalty program dressed as a discount schedule” [3].

NovoCare’s offer is $199 per month for the first two months for new self-pay patients on Wegovy or Ozempic injectables at the 0.25 mg or 0.5 mg dose amounts, after which the price steps up to $349 [3][7]. Swanson described that structure as a “classic acquisition funnel” [3]. Both companies have a commercial interest in steering patients to their own channels; the quotes from analysts are their opinions, not company statements.

What are Amazon, Walmart, Costco and CVS offering?

Amazon. Amazon Pharmacy added the Zepbound KwikPen on March 9, 2026, with self-pay pricing starting at $299 per month for the 2.5 mg starter [4]. The KwikPen is a multi-dose device that holds a full month of medication in a single pen [4]. Amazon Pharmacy also offers the Wegovy pill and Foundayo orally from $149 per month cash, and Wegovy injectables, the Zepbound auto-injector, and KwikPen from $299 per month cash [6]. Insured prices start as low as $25 a month [3][6]. Delivery reaches all 50 states, with same-day delivery in nearly 3,000 cities and towns, expanding to about 4,500 by the end of 2026 [6][4]. Amazon auto-applies eligible manufacturer coupons at checkout and says customers have saved more than $200 million through that program, with GLP-1s the largest savings category [4][6].

Amazon’s One Medical GLP-1 Management Program launched in April 2026 and does not require a One Medical membership [6][3]. It includes pre-visit screening, structured consultations, and regular follow-up visits [6]. Separately, people who already have a GLP-1 prescription can get 24/7 cash-pay virtual renewal visits, with the medication cost separate from the visit cost [6].

Walmart. Walmart serves as a retail pickup point for LillyDirect-priced Zepbound vials, with prescriptions routed through the prescriber’s electronic health record to LillyDirect Self Pay Pharmacy Solutions [7]. In April 2026, Walmart expanded its Better Care Services platform to bundle GLP-1 prescriptions with nutrition coaching, fitness apps, and AI-driven coaching tools [3]. Walmart runs nearly 4,600 pharmacies and is the nation’s fifth-largest prescription provider [3].

Costco. Costco’s partnership with Sesame prices Wegovy at around $349 a month and requires a Costco membership — which, as Swanson put it, means “the prescription now helps sell the $65 card” [3].

CVS. CVS Pharmacy stocks all FDA-approved GLP-1s, oral and injectable, through insurance or cash pay [8]. Its MinuteClinic online weight-loss visit costs $29, is available 24/7, and has no membership or recurring monthly fee [8]. Through a collaboration with Eli Lilly, by early fourth quarter of 2026, eligible Zepbound and Foundayo patients will be able to view transparent pricing, including cash-pay options, in the CVS Health app, with same-day pickup at about 9,000 locations [8]. CVS also accepts third-party discount cards, manufacturer coupons, and manufacturer vouchers [8].

Mention of these sellers is factual market coverage, not an endorsement, and each company quoted — Amazon, CVS, Lilly, and Novo — was promoting its own program.

What does Medicare’s $50 GLP-1 Bridge program cover?

The CMS Medicare GLP-1 Bridge program lets eligible Medicare beneficiaries access certain GLP-1 medications for $50 per month, and it runs through December 31, 2027 [8]. CVS Pharmacy participates in the Bridge [8].

The backdrop matters: federal law, under a 2003 provision, bars Medicare from covering weight-loss medications because they were considered cosmetic [5]. The Treat and Reduce Obesity Act (S. 1973) would let Medicare cover anti-obesity medications for people who are overweight and have one or more other medical conditions [5]. The Congressional Budget Office estimated that Medicare coverage of anti-obesity medications would cost $35 billion over nine years [5]. In the meantime, CMS is running a voluntary demonstration this year that lets some Medicare and Medicaid beneficiaries access GLP-1s for obesity treatment [5].

Is compounded semaglutide cheaper — and is it the same thing?

Compounded copies of GLP-1 drugs are often cheaper, but they are not FDA-approved products and receive less oversight than approved medications [5]. FDA guidance issued in 2026 recommends compounded GLP-1s only when an FDA-approved drug isn’t available or isn’t meeting the patient’s needs [5].

Congress is weighing a crackdown. The pending Safeguarding Americans from Fraudulent and Experimental Drugs Act (S. 3794) would give the FDA more authority over compounders, including mandatory activity reporting, inspections, and monthly limits on how many “copies” of a drug can be produced [5]. “Americans deserve confidence that their prescription medications are safe, effective and made to the highest quality standards,” Rep. Rudy Yakym (R-Ind.) said in a press release on the bill [5]. No compounded product should be assumed to be FDA-approved or therapeutically equivalent to an approved drug.

Why are retailers fighting so hard over these prescriptions?

Because a GLP-1 prescription is a recurring relationship. “Retailers are betting that if they can become the front door for obesity care, they’ll earn a relationship that extends far beyond a single GLP-1 prescription,” said Eric Bormel, managing director specializing in digital healthcare at Solomon Partners’ healthcare group [3]. Swanson’s framing: “Pharmacy lock-in is loyalty-program economics applied to medicine, and it works because the refill, unlike almost everything else in retail, is non-negotiable” [3].

When a discount is tied to a network, the patient’s choice of pharmacy happens at sign-up rather than at the counter, which favors large chains over independents [3]. By Drug Channels Institute’s most recent published data, CVS holds 14.7% of the pharmacy market, Walgreens 14.6%, and Walmart 4.8% [3].

Retailers’ healthcare track record is worth remembering: Walmart closed all 51 of its Walmart Health clinics in 2024, Amazon shut its Amazon Care telehealth service at the end of 2022, the Haven venture dissolved in 2021, and CVS has closed many MinuteClinics [3]. “Sales dollars are a lot bigger than the margin dollars,” Kroger CEO Rodney McMullen said in 2023 [3].

What tradeoffs hide behind the sticker price?

The biggest one is drug-interaction screening. Dared Price, who owns nine pharmacies in small Kansas towns like Winfield (population 11,000), said that when his customers fill GLP-1s through a DTC program at CVS or Costco, those pharmacies don’t see the rest of the patient’s medication list — and his system can’t flag interactions either [3]. “My system won’t flag any drug interactions with GLP drugs and there are drug interactions that can be dangerous,” Price said, citing known interactions with drugs like insulin and oral contraceptives [3].

Seth Friedman, pharmacy and health plan services practice leader at Gallagher, said smaller pharmacies stand to lose volume in this shift [3]. CVS’s own senior vice president, Sid Tenneti, countered that CVS’s model has no separate memberships, no mail-order-only access, and no fragmented handoffs [8] — a statement from an interested party, as are the analysts’ quotes.

Fees also stack. A Costco membership or a visit fee sits on top of the drug price [3], and at Amazon, the cost of a telehealth renewal visit is separate from the medication cost [6].

How do you compare and lock in the lowest price?

  1. Check your plan coverage first. Prior authorization requirements and varying coverage are common barriers [8].
  2. Compare insurance versus cash side by side. Amazon Pharmacy shows both at checkout [6], and the CVS Health app will show transparent pricing including cash-pay options for eligible Zepbound and Foundayo patients by early fourth quarter of 2026 [8].
  3. Ask about coupons and vouchers. At CVS, the out-of-pocket cost can be as low as $25 a month through commercial insurance with a manufacturer coupon for eligible patients, or $149 without insurance using a manufacturer voucher for qualifying medications and doses [8]. Amazon auto-applies eligible manufacturer coupons [4][6].
  4. Read the refill conditions. LillyDirect’s better pricing is tied to refilling within 45 days [3].
  5. Check whether a price is introductory. NovoCare’s $199 steps up to $349 [3][7], and some TrumpRx-listed reduced costs are time-limited [5].
  6. Ask what clinical follow-up is included. Amazon One Medical’s program includes structured consultations and follow-up visits [6]; CVS’s $29 MinuteClinic visit includes evaluation by a licensed clinician [8].
  7. Tell your regular pharmacist. If you fill a GLP-1 elsewhere, let your usual pharmacy know so its interaction screening can work [3].

What could change prices again?

Semaglutide began losing exclusivity in early 2026 across India, China, Brazil, Turkey, and Canada, with India’s loss of exclusivity on March 20, 2026 [2]. IQVIA counts 74 Chinese developers working on generic semaglutide, alongside growing manufacturing activity in India [2]. Foundayo (orflorglipron), an oral small-molecule GLP-1, reached the US market in April 2026 [2]. The global obesity medicines market reached $66 billion in list-price sales in 2025 and is forecast at $92 billion in 2026 [2]. Wegovy HD (7.2 mg) was approved and launched in the US in April 2026 [1].

On the policy side, President Trump has pushed a Most Favored Nation approach that would peg US prices to cheaper foreign prices; Congress has so far resisted [5]. The TrumpRx site offers coupons or direct manufacturer purchase [5]. Any of these could move the numbers again, which is one more reason to verify prices before each purchase.

Sources

  1. Novo Nordisk. Financial report for the period 1 January 2026 to 30 June 2026. August 4, 2026.
  2. IQVIA. The outlook for obesity from 2026 to 2030. April 21, 2026.
  3. CNBC. As Americans go direct with GLP-1 prescriptions, Walmart, Costco, Amazon will be big weight-loss winners. August 1, 2026.
  4. HIT Consultant. GLP-1: Amazon Pharmacy adds Zepbound KwikPen to its same-day delivery. March 9, 2026.
  5. Bloomberg Government. Congress takes fresh look at GLP-1 legislation on cost, safety.
  6. Amazon. Amazon One Medical introduces weight management program with upfront GLP-1 medication costs. April 21, 2026.
  7. Pharmaceutical Executive. Lilly reduces price of Zepbound single-dose vials for self-pay patients. December 1, 2025.
  8. Yahoo Finance. CVS Health enhances its direct-to-consumer weight management offerings to improve access, affordability, care and support for GLP-1 medications.
  9. DistilINFO Publications. Walgreens joins Medicare GLP-1 Bridge drug program. June 26, 2026.
  10. Business Wire. Walgreens Virtual Healthcare adds weight management services to support patients on their weight loss journey.
  11. NPR. Drugstores say Medicare’s $50 obesity drug program is catching on. August 26, 2026.
  12. Forbes Health. 6 cheapest online semaglutide providers (2026). September 11, 2026.
  13. Sherwood News. How Novo Nordisk’s new Wegovy pill is transforming the weight-loss drug market. February 2, 2026.
  14. GLP Chart. Compounded GLP-1 by medication: which programs offer each (2026). September 14, 2026.
  15. National Council on Aging. Medicare GLP-1 Bridge Program: eligibility, costs, and coverage.
  16. Medscape. Novo Nordisk to halve US list price of Wegovy from 2027. February 24, 2026.
  17. CVS Health. CVS Caremark delivers affordability and access to GLP-1 weight management medications with expanded coverage options. May 28, 2026.

Frequently asked questions

Is Wegovy or Zepbound cheaper if you pay cash instead of using insurance?

It depends on your coverage. With commercial insurance plus a manufacturer coupon, CVS lists out-of-pocket costs as low as $25 a month for eligible patients. Without insurance, cash channels start around $149 for oral GLP-1s at Amazon Pharmacy and $299 for injectables, versus quotes upwards of $1,000 at a traditional pharmacy counter without a program.

Where is the cheapest place to get the Wegovy pill versus the injection?

For the oral form, Amazon Pharmacy lists cash-pay options from $149 per month for the Wegovy pill and Foundayo. For injectables, Amazon lists Wegovy injectable, Zepbound auto-injector, and KwikPen from $299 per month cash, matching LillyDirect's $299 entry vial price. Verify current prices before buying, since these are 2026 snapshots.

Is Amazon, Costco, CVS, or the manufacturer site cheapest?

There is no single winner. LillyDirect runs $299 to $449 a month for Zepbound vials; NovoCare starts at $199 before stepping to $349; Costco's Sesame partnership prices Wegovy around $349 with a required membership; CVS can reach $149 uninsured with a manufacturer voucher on qualifying medications and doses. Compare at checkout, since conditions differ.

What does the Medicare $50 GLP-1 program cover, and who is excluded?

The CMS Medicare GLP-1 Bridge program offers certain GLP-1 medications to eligible Medicare beneficiaries for $50 per month and runs through December 31, 2027; CVS Pharmacy participates. Federal law still bars Medicare from covering weight-loss drugs under a 2003 provision treating them as cosmetic, and the Treat and Reduce Obesity Act (S. 1973) would change that.

Does a cash GLP-1 payment count toward a deductible?

Amazon notes that copays and deductibles may apply when One Medical visits are billed to insurance, but nothing in these sources states how cash-pay drug purchases are treated for deductible purposes. Check with your plan before assuming a cash purchase counts.

Is compounded semaglutide still cheaper, and is it legal and safe?

Compounded copies are often cheaper but receive less oversight than FDA-approved products and are not FDA-approved drugs themselves. FDA guidance from 2026 recommends compounded GLP-1s only when an FDA-approved drug isn't available or isn't meeting the patient's needs. A pending bill, S. 3794, would add mandatory reporting, inspections, and monthly limits on copies.

What happens to the price if you miss a refill window?

LillyDirect's better Zepbound pricing is conditioned on refilling within 45 days, so missing that window can cost you the lower price. Analyst Jackie Swanson of Gartner called the structure "a loyalty program dressed as a discount schedule". Check the terms before you sign up.

Are telehealth memberships worth it on top of the drug cost?

Sometimes you don't need one. CVS's MinuteClinic online weight-loss visit is $29 with no membership or recurring monthly fee, and Amazon's One Medical GLP-1 program doesn't require a membership, though medication costs are separate from visit costs. Costco's Wegovy pricing requires a $65 membership. Compare the total of fees plus drug price, not the drug price alone.

This article summarizes FDA labeling, published research and company information current as of September 14, 2026. It is not medical advice and does not replace a conversation with your own healthcare provider. How we research and verify.